▶ 調査レポート

膝蓋前滑液包炎治療の世界市場(~2026年)

• 英文タイトル:Global Knee Bursitis Treatment Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。膝蓋前滑液包炎治療の世界市場(~2026年) / Global Knee Bursitis Treatment Market Size, Status and Forecast 2020-2026 / MRC2-11QY12463資料のイメージです。• レポートコード:MRC2-11QY12463
• 出版社/出版日:QYResearch / 2020年11月25日
• レポート形態:英文、PDF、96ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥444,600 (USD3,900)▷ お問い合わせ
  Multi User¥666,900 (USD5,850)▷ お問い合わせ
  Enterprise License¥889,200 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は膝蓋前滑液包炎治療のグローバル市場について調査・分析したレポートです。種類別(投薬、外科治療、その他)市場規模、用途別(病院、クリニック、皮膚科センター、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別膝蓋前滑液包炎治療の競争状況、市場シェア
・世界の膝蓋前滑液包炎治療市場:種類別市場規模 2015年-2020年(投薬、外科治療、その他)
・世界の膝蓋前滑液包炎治療市場:種類別市場規模予測 2021年-2026年(投薬、外科治療、その他)
・世界の膝蓋前滑液包炎治療市場:用途別市場規模 2015年-2020年(病院、クリニック、皮膚科センター、その他)
・世界の膝蓋前滑液包炎治療市場:用途別市場規模予測 2021年-2026年(病院、クリニック、皮膚科センター、その他)
・北米の膝蓋前滑液包炎治療市場分析:米国、カナダ
・ヨーロッパの膝蓋前滑液包炎治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの膝蓋前滑液包炎治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の膝蓋前滑液包炎治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの膝蓋前滑液包炎治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Novartis、Pfizer、Merck、Amgen、Bayer、AVEO Pharmaceuticals、Bellicum Pharmaceuticals、MediaPharma、Merrimack Pharmaceuticals、Oncolys BioPharma、United Therapeutics
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Knee bursitis is inflammation of a small fluid-filled sac (bursa) situated near the knee joint. Bursae reduce friction and cushion pressure points between bones and the tendons, muscles, and skin near joints. Knee bursitis signs and symptoms vary, depending on which bursa is affected and what’s causing the inflammation. Generally, the affected portion of knee might feel warm, tender, and swollen when pressure is applied.
The Asia Pacific is the fastest growing knee bursitis market. Increasing need for better devices, rapidly improving technology, and the presence of huge patient pool is driving the growth of the market in this region.

Market Analysis and Insights: Global Knee Bursitis Treatment Market
The global Knee Bursitis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Knee Bursitis Treatment Scope and Market Size
Knee Bursitis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Knee Bursitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Novartis
Pfizer
Merck
Amgen
Bayer
AVEO Pharmaceuticals
Bellicum Pharmaceuticals
MediaPharma
Merrimack Pharmaceuticals
Oncolys BioPharma
United Therapeutics

Market segment by Type, the product can be split into
Medication
Surgery Therapy
Others
Market segment by Application, split into
Hospitals
Clinics
Dermatology Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Knee Bursitis Treatment Revenue
1.4 Market by Type
1.4.1 Global Knee Bursitis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Medication
1.4.3 Surgery Therapy
1.4.4 Others
1.5 Market by Application
1.5.1 Global Knee Bursitis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Dermatology Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Knee Bursitis Treatment Market Perspective (2015-2026)
2.2 Global Knee Bursitis Treatment Growth Trends by Regions
2.2.1 Knee Bursitis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Knee Bursitis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Knee Bursitis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Knee Bursitis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Knee Bursitis Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Knee Bursitis Treatment Players by Market Size
3.1.1 Global Top Knee Bursitis Treatment Players by Revenue (2015-2020)
3.1.2 Global Knee Bursitis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Knee Bursitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Knee Bursitis Treatment Market Concentration Ratio
3.2.1 Global Knee Bursitis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Knee Bursitis Treatment Revenue in 2019
3.3 Knee Bursitis Treatment Key Players Head office and Area Served
3.4 Key Players Knee Bursitis Treatment Product Solution and Service
3.5 Date of Enter into Knee Bursitis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Knee Bursitis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Knee Bursitis Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Knee Bursitis Treatment Market Size by Application (2015-2020)
5.2 Global Knee Bursitis Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Knee Bursitis Treatment Market Size (2015-2020)
6.2 Knee Bursitis Treatment Key Players in North America (2019-2020)
6.3 North America Knee Bursitis Treatment Market Size by Type (2015-2020)
6.4 North America Knee Bursitis Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Knee Bursitis Treatment Market Size (2015-2020)
7.2 Knee Bursitis Treatment Key Players in Europe (2019-2020)
7.3 Europe Knee Bursitis Treatment Market Size by Type (2015-2020)
7.4 Europe Knee Bursitis Treatment Market Size by Application (2015-2020)

8 China
8.1 China Knee Bursitis Treatment Market Size (2015-2020)
8.2 Knee Bursitis Treatment Key Players in China (2019-2020)
8.3 China Knee Bursitis Treatment Market Size by Type (2015-2020)
8.4 China Knee Bursitis Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Knee Bursitis Treatment Market Size (2015-2020)
9.2 Knee Bursitis Treatment Key Players in Japan (2019-2020)
9.3 Japan Knee Bursitis Treatment Market Size by Type (2015-2020)
9.4 Japan Knee Bursitis Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Knee Bursitis Treatment Market Size (2015-2020)
10.2 Knee Bursitis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Knee Bursitis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Knee Bursitis Treatment Market Size by Application (2015-2020)

11 India
11.1 India Knee Bursitis Treatment Market Size (2015-2020)
11.2 Knee Bursitis Treatment Key Players in India (2019-2020)
11.3 India Knee Bursitis Treatment Market Size by Type (2015-2020)
11.4 India Knee Bursitis Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Knee Bursitis Treatment Market Size (2015-2020)
12.2 Knee Bursitis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Knee Bursitis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Knee Bursitis Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Knee Bursitis Treatment Introduction
13.1.4 Novartis Revenue in Knee Bursitis Treatment Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Knee Bursitis Treatment Introduction
13.2.4 Pfizer Revenue in Knee Bursitis Treatment Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Knee Bursitis Treatment Introduction
13.3.4 Merck Revenue in Knee Bursitis Treatment Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Amgen
13.4.1 Amgen Company Details
13.4.2 Amgen Business Overview
13.4.3 Amgen Knee Bursitis Treatment Introduction
13.4.4 Amgen Revenue in Knee Bursitis Treatment Business (2015-2020)
13.4.5 Amgen Recent Development
13.5 Bayer
13.5.1 Bayer Company Details
13.5.2 Bayer Business Overview
13.5.3 Bayer Knee Bursitis Treatment Introduction
13.5.4 Bayer Revenue in Knee Bursitis Treatment Business (2015-2020)
13.5.5 Bayer Recent Development
13.6 AVEO Pharmaceuticals
13.6.1 AVEO Pharmaceuticals Company Details
13.6.2 AVEO Pharmaceuticals Business Overview
13.6.3 AVEO Pharmaceuticals Knee Bursitis Treatment Introduction
13.6.4 AVEO Pharmaceuticals Revenue in Knee Bursitis Treatment Business (2015-2020)
13.6.5 AVEO Pharmaceuticals Recent Development
13.7 Bellicum Pharmaceuticals
13.7.1 Bellicum Pharmaceuticals Company Details
13.7.2 Bellicum Pharmaceuticals Business Overview
13.7.3 Bellicum Pharmaceuticals Knee Bursitis Treatment Introduction
13.7.4 Bellicum Pharmaceuticals Revenue in Knee Bursitis Treatment Business (2015-2020)
13.7.5 Bellicum Pharmaceuticals Recent Development
13.8 MediaPharma
13.8.1 MediaPharma Company Details
13.8.2 MediaPharma Business Overview
13.8.3 MediaPharma Knee Bursitis Treatment Introduction
13.8.4 MediaPharma Revenue in Knee Bursitis Treatment Business (2015-2020)
13.8.5 MediaPharma Recent Development
13.9 Merrimack Pharmaceuticals
13.9.1 Merrimack Pharmaceuticals Company Details
13.9.2 Merrimack Pharmaceuticals Business Overview
13.9.3 Merrimack Pharmaceuticals Knee Bursitis Treatment Introduction
13.9.4 Merrimack Pharmaceuticals Revenue in Knee Bursitis Treatment Business (2015-2020)
13.9.5 Merrimack Pharmaceuticals Recent Development
13.10 Oncolys BioPharma
13.10.1 Oncolys BioPharma Company Details
13.10.2 Oncolys BioPharma Business Overview
13.10.3 Oncolys BioPharma Knee Bursitis Treatment Introduction
13.10.4 Oncolys BioPharma Revenue in Knee Bursitis Treatment Business (2015-2020)
13.10.5 Oncolys BioPharma Recent Development
13.11 United Therapeutics
10.11.1 United Therapeutics Company Details
10.11.2 United Therapeutics Business Overview
10.11.3 United Therapeutics Knee Bursitis Treatment Introduction
10.11.4 United Therapeutics Revenue in Knee Bursitis Treatment Business (2015-2020)
10.11.5 United Therapeutics Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Knee Bursitis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Knee Bursitis Treatment Revenue
Table 3. Ranking of Global Top Knee Bursitis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Knee Bursitis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medication
Table 6. Key Players of Surgery Therapy
Table 7. Key Players of Others
Table 8. Global Knee Bursitis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Knee Bursitis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Knee Bursitis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Knee Bursitis Treatment Market Share by Regions (2015-2020)
Table 12. Global Knee Bursitis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Knee Bursitis Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Knee Bursitis Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Knee Bursitis Treatment Players
Table 19. Global Knee Bursitis Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Knee Bursitis Treatment Market Share by Players (2015-2020)
Table 21. Global Top Knee Bursitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Knee Bursitis Treatment as of 2019)
Table 22. Global Knee Bursitis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Knee Bursitis Treatment Product Solution and Service
Table 25. Date of Enter into Knee Bursitis Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Knee Bursitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Knee Bursitis Treatment Market Size Share by Type (2015-2020)
Table 29. Global Knee Bursitis Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Knee Bursitis Treatment Market Size Share by Application (2015-2020)
Table 31. Global Knee Bursitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Knee Bursitis Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Knee Bursitis Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Knee Bursitis Treatment Market Share (2019-2020)
Table 35. North America Knee Bursitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Knee Bursitis Treatment Market Share by Type (2015-2020)
Table 37. North America Knee Bursitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Knee Bursitis Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Knee Bursitis Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Knee Bursitis Treatment Market Share (2019-2020)
Table 41. Europe Knee Bursitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Knee Bursitis Treatment Market Share by Type (2015-2020)
Table 43. Europe Knee Bursitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Knee Bursitis Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Knee Bursitis Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Knee Bursitis Treatment Market Share (2019-2020)
Table 47. China Knee Bursitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Knee Bursitis Treatment Market Share by Type (2015-2020)
Table 49. China Knee Bursitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Knee Bursitis Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Knee Bursitis Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Knee Bursitis Treatment Market Share (2019-2020)
Table 53. Japan Knee Bursitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Knee Bursitis Treatment Market Share by Type (2015-2020)
Table 55. Japan Knee Bursitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Knee Bursitis Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Knee Bursitis Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Knee Bursitis Treatment Market Share (2019-2020)
Table 59. Southeast Asia Knee Bursitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Knee Bursitis Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Knee Bursitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Knee Bursitis Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Knee Bursitis Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Knee Bursitis Treatment Market Share (2019-2020)
Table 65. India Knee Bursitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Knee Bursitis Treatment Market Share by Type (2015-2020)
Table 67. India Knee Bursitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Knee Bursitis Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Knee Bursitis Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Knee Bursitis Treatment Market Share (2019-2020)
Table 71. Central & South America Knee Bursitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Knee Bursitis Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Knee Bursitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Knee Bursitis Treatment Market Share by Application (2015-2020)
Table 75. Novartis Company Details
Table 76. Novartis Business Overview
Table 77. Novartis Product
Table 78. Novartis Revenue in Knee Bursitis Treatment Business (2015-2020) (Million US$)
Table 79. Novartis Recent Development
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Knee Bursitis Treatment Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Product
Table 88. Merck Revenue in Knee Bursitis Treatment Business (2015-2020) (Million US$)
Table 89. Merck Recent Development
Table 90. Amgen Company Details
Table 91. Amgen Business Overview
Table 92. Amgen Product
Table 93. Amgen Revenue in Knee Bursitis Treatment Business (2015-2020) (Million US$)
Table 94. Amgen Recent Development
Table 95. Bayer Company Details
Table 96. Bayer Business Overview
Table 97. Bayer Product
Table 98. Bayer Revenue in Knee Bursitis Treatment Business (2015-2020) (Million US$)
Table 99. Bayer Recent Development
Table 100. AVEO Pharmaceuticals Company Details
Table 101. AVEO Pharmaceuticals Business Overview
Table 102. AVEO Pharmaceuticals Product
Table 103. AVEO Pharmaceuticals Revenue in Knee Bursitis Treatment Business (2015-2020) (Million US$)
Table 104. AVEO Pharmaceuticals Recent Development
Table 105. Bellicum Pharmaceuticals Company Details
Table 106. Bellicum Pharmaceuticals Business Overview
Table 107. Bellicum Pharmaceuticals Product
Table 108. Bellicum Pharmaceuticals Revenue in Knee Bursitis Treatment Business (2015-2020) (Million US$)
Table 109. Bellicum Pharmaceuticals Recent Development
Table 110. MediaPharma Business Overview
Table 111. MediaPharma Product
Table 112. MediaPharma Company Details
Table 113. MediaPharma Revenue in Knee Bursitis Treatment Business (2015-2020) (Million US$)
Table 114. MediaPharma Recent Development
Table 115. Merrimack Pharmaceuticals Company Details
Table 116. Merrimack Pharmaceuticals Business Overview
Table 117. Merrimack Pharmaceuticals Product
Table 118. Merrimack Pharmaceuticals Revenue in Knee Bursitis Treatment Business (2015-2020) (Million US$)
Table 119. Merrimack Pharmaceuticals Recent Development
Table 120. Oncolys BioPharma Company Details
Table 121. Oncolys BioPharma Business Overview
Table 122. Oncolys BioPharma Product
Table 123. Oncolys BioPharma Revenue in Knee Bursitis Treatment Business (2015-2020) (Million US$)
Table 124. Oncolys BioPharma Recent Development
Table 125. United Therapeutics Company Details
Table 126. United Therapeutics Business Overview
Table 127. United Therapeutics Product
Table 128. United Therapeutics Revenue in Knee Bursitis Treatment Business (2015-2020) (Million US$)
Table 129. United Therapeutics Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Knee Bursitis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Medication Features
Figure 3. Surgery Therapy Features
Figure 4. Others Features
Figure 5. Global Knee Bursitis Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Dermatology Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Knee Bursitis Treatment Report Years Considered
Figure 11. Global Knee Bursitis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Knee Bursitis Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Knee Bursitis Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Knee Bursitis Treatment Market Share by Players in 2019
Figure 16. Global Top Knee Bursitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Knee Bursitis Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Knee Bursitis Treatment Revenue in 2019
Figure 18. North America Knee Bursitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Knee Bursitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Knee Bursitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Knee Bursitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Knee Bursitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Knee Bursitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Knee Bursitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed